IGC Receives U.S. Patent for Method and Composition for Treating Seizure Disorders
![](https://mms.businesswire.com/media/20220608006202/en/650703/4/IGC_New_Logo_High.jpg)
The patent is assigned to IGC and relates to compositions and methods for treating multiple types of seizure disorders and epilepsy in humans and animals, using a combination of the cannabinoid cannabidiol (CBD) with other compounds.